https://www.indianpharmapost.com/vimta-labs-posts-q4-fy25-pat-at-rs-1831-cr-170922025-05-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/sigachi-industries-signs-mou-with-respilon-group-170932025-05-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-inspects-marksanss-subsidiary-time-cap-laboratories-manufacturing-facility-170942025-05-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/strides-receives-usfda-approval-for-anti-inflammatory-celecoxib-capsules-170952025-05-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/chmp-recommends-eu-label-update-for-roches-phesgo-to-allow-administration-outside-of-clinical-settings-170962025-05-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/briefs-alembic-pharmaceuticals-and-bafna-pharmaceuticals-170972025-05-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-morepen-launches-rs-499-annual-multivitamin-pack-on-labours-day-170982025-05-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/aster-dm-healthcare-completes-acquisition-of-5-stake-in-quality-care-india-170992025-05-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/gland-pharma-receives-usfda-approval-for-latanoprostene-bunod-ophthalmic-solution-171002025-05-01T00:00:00+05:30always0.9